Treatment of acute myelogenous leukaemia in patients aged 50–65: idarubicin is more effective than zorubicin for remission induction and prolonged disease‐free survival can be obtained using a unique consolidation course

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|7-1048|2|333-341

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.7-1048, Iss.2, 1996-08, pp. : 333-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of acute myelogenous leukaemia in patients aged 50–65: idarubicin is more effective than zorubicin for remission induction and prolonged disease‐free survival can be obtained using a unique consolidation course

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 333-341

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effective mobilization of Philadelphia‐chromosome‐negative cells in chronic myelogenous leukaemia patients using a less intensive regimen

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 445-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Nomogram for Disease-Free Survival in Patients with Renal Adenocarcinoma

By  

Urologia Internationalis, Vol. 88, Iss. 3, 2012-02 ,pp. : 271-276

Karger

Access to resources Recommend Favorite

Lung metastases from differentiated thyroid carcinoma: prognostic factors related to remission and disease‐free survival

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 3, 2015-03 ,pp. : 445-452

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment‐free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 2, 2015-01 ,pp. : 305-308

John Wiley & Sons Inc

Access to resources Recommend Favorite